$ANIX
Anixa Biosciences Inc

2022 Q3 Form 10-Q Financial Statement

#000149315222025490 Filed on September 09, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2021 Q4 2021 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.352M $1.904M $2.222M
YoY Change -39.14% 4.03% 88.27%
% of Gross Profit
Research & Development $1.445M $2.173M $2.167M
YoY Change -33.31% 430.06% 73.33%
% of Gross Profit
Depreciation & Amortization $0.00 $0.00
YoY Change -100.0%
% of Gross Profit
Operating Expenses $1.445M $4.077M $4.388M
YoY Change -67.07% 82.01% 79.85%
Operating Profit -$2.797M -$4.388M
YoY Change -36.26%
Interest Expense $22.00K $550.00 $630.00
YoY Change 3392.06% -93.7%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$2.775M -$4.071M -$4.388M
YoY Change -36.75% 81.74% 70.06%
Income Tax
% Of Pretax Income
Net Earnings -$2.746M -$4.013M -$4.334M
YoY Change -36.64% 80.78% 69.3%
Net Earnings / Revenue
Basic Earnings Per Share -$0.09 -$0.14
Diluted Earnings Per Share -$90.18K -$133.6K -$142.3K
COMMON SHARES
Basic Shares Outstanding 30.66M shares
Diluted Shares Outstanding 30.45K shares 30.46K shares

Balance Sheet

Concept 2022 Q3 2021 Q4 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $31.66M $35.73M $36.62M
YoY Change -13.54% 294.35% 303.77%
Cash & Equivalents $24.25M $29.13M $27.22M
Short-Term Investments $7.410M $6.600M $9.400M
Other Short-Term Assets $676.0K $275.6K $430.0K
YoY Change 57.21% -11.11% 126.32%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $32.34M $36.00M $37.05M
YoY Change -12.72% 284.24% 300.13%
LONG-TERM ASSETS
Property, Plant & Equipment $223.0K $254.0K $10.41K
YoY Change 2042.17% 407.92% -85.13%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Assets $223.0K $254.0K $10.41K
YoY Change 2042.17% 206.1% -89.59%
TOTAL ASSETS
Total Short-Term Assets $32.34M $36.00M $37.05M
Total Long-Term Assets $223.0K $254.0K $10.41K
Total Assets $32.56M $36.26M $37.06M
YoY Change -12.14% 283.56% 295.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $227.0K $136.2K $207.7K
YoY Change 9.28% -40.78% -38.9%
Accrued Expenses $1.198M $1.134M $1.000M
YoY Change 19.77% 18.16% 14.98%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.469M $1.271M $1.208M
YoY Change 21.6% 6.77% -0.16%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $187.0K $220.1K
YoY Change
Total Long-Term Liabilities $187.0K $220.1K $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.469M $1.271M $1.208M
Total Long-Term Liabilities $187.0K $220.1K $0.00
Total Liabilities $1.656M $820.1K $595.3K
YoY Change 178.18% 18.86% -19.55%
SHAREHOLDERS EQUITY
Retained Earnings -$214.9M -$204.8M
YoY Change
Common Stock $307.0K $301.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $31.70M $35.44M $36.47M
YoY Change
Total Liabilities & Shareholders Equity $32.56M $36.26M $37.06M
YoY Change -12.14% 283.68% 295.97%

Cashflow Statement

Concept 2022 Q3 2021 Q4 2021 Q3
OPERATING ACTIVITIES
Net Income -$2.746M -$4.013M -$4.334M
YoY Change -36.64% 80.78% 69.3%
Depreciation, Depletion And Amortization $0.00 $0.00
YoY Change -100.0%
Cash From Operating Activities -$1.396M -$1.044M -$1.481M
YoY Change -5.72% -26.47% 14.79%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$2.911M $2.807M $999.5K
YoY Change -391.24% 461.33% -292.21%
Cash From Investing Activities -$2.911M $2.807M $999.5K
YoY Change -391.24% 461.33% -292.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$2.405M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 829.0K 143.6K 0.000
YoY Change -89.81% -100.0%
NET CHANGE
Cash From Operating Activities -1.396M -1.044M -1.481M
Cash From Investing Activities -2.911M 2.807M 999.5K
Cash From Financing Activities 829.0K 143.6K 0.000
Net Change In Cash -3.478M 1.906M -481.3K
YoY Change 622.7% 289.0% -115.83%
FREE CASH FLOW
Cash From Operating Activities -$1.396M -$1.044M -$1.481M
Capital Expenditures $0.00 $0.00
Free Cash Flow -$1.044M -$1.481M
YoY Change -26.47% 14.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
ANIX Payments Of Market Offering
PaymentsOfMarketOffering
usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
usd
CY2022Q3 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
usd
dei Document Type
DocumentType
10-Q
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q3 us-gaap Interest Income Other
InterestIncomeOther
usd
CY2021Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
ANIX Common Stock Issued To Consultants
CommonStockIssuedToConsultants
usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
dei Entity Central Index Key
EntityCentralIndexKey
0000715446
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--10-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Document Period End Date
DocumentPeriodEndDate
2022-07-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37492
dei Entity Registrant Name
EntityRegistrantName
ANIXA BIOSCIENCES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
11-2622630
dei Entity Address Address Line1
EntityAddressAddressLine1
3150 Almaden Expressway
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 250
dei Entity Address City Or Town
EntityAddressCityOrTown
San Jose
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95118
dei City Area Code
CityAreaCode
(408)
dei Local Phone Number
LocalPhoneNumber
708-9808
dei Security12b Title
Security12bTitle
Common Stock, par value $.01 per share
dei Trading Symbol
TradingSymbol
ANIX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
30661692 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24254000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29128000 usd
CY2022Q3 us-gaap Short Term Investments
ShortTermInvestments
7410000 usd
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
6599000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
676000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
276000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
32340000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
36003000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
223000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
254000 usd
CY2022Q3 us-gaap Assets
Assets
32563000 usd
CY2021Q4 us-gaap Assets
Assets
36257000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
227000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
136000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1198000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1095000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
44000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
39000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1469000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1270000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
187000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
220000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
1656000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
1490000 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
100
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
100
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
19860 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
19860 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30653418 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30653418 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30050894 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30050894 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
307000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
301000 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
246303000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
239927000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-214909000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-204790000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
31701000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
35438000 usd
CY2022Q3 us-gaap Minority Interest
MinorityInterest
-794000 usd
CY2021Q4 us-gaap Minority Interest
MinorityInterest
-671000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
30907000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
34767000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
32563000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
36257000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
513000 usd
us-gaap Royalty Expense
RoyaltyExpense
385000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1445000 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2167000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5018000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4017000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1352000 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2221000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5248000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5170000 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
2797000 usd
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
4388000 usd
us-gaap Costs And Expenses
CostsAndExpenses
10266000 usd
us-gaap Costs And Expenses
CostsAndExpenses
9572000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2797000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4388000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-10266000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-9059000 usd
CY2022Q3 us-gaap Interest Income Other
InterestIncomeOther
22000 usd
us-gaap Interest Income Other
InterestIncomeOther
24000 usd
us-gaap Interest Income Other
InterestIncomeOther
2000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-2775000 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-4388000 usd
us-gaap Profit Loss
ProfitLoss
-10242000 usd
us-gaap Profit Loss
ProfitLoss
-9057000 usd
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-29000 usd
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-54000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-123000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-116000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2746000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-4334000 usd
us-gaap Net Income Loss
NetIncomeLoss
-10119000 usd
us-gaap Net Income Loss
NetIncomeLoss
-8941000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.32
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30451 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30455 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30244 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28090 shares
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
31406000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1329000 usd
CY2022Q3 ANIX Adjustments To Additional Paid In Capital Stock Option And Warrants Issued Value
AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue
109000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
830000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
8000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-2775000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
30907000 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
37055000 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
3048000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
139000 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-4388000 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
35854000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
34767000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
4928000 usd
ANIX Adjustments To Additional Paid In Capital Stock Option And Warrants Issued Value
AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue
546000 usd
ANIX Stock Issued During Period Value Stock Optionsand Warrants Exercised
StockIssuedDuringPeriodValueStockOptionsandWarrantsExercised
830000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
72000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
6000 usd
us-gaap Profit Loss
ProfitLoss
-10242000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
30907000 usd
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8264000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
4804000 usd
ANIX Adjustments To Additional Paid In Capital Stock Option And Warrants Issued Value
AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue
421000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
293000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2208000 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
20292000 usd
ANIX Expenses Of Atthemarket Offering
ExpensesOfAtthemarketOffering
341000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10834000 usd
us-gaap Profit Loss
ProfitLoss
-9057000 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
35854000 usd
us-gaap Profit Loss
ProfitLoss
-10242000 usd
us-gaap Profit Loss
ProfitLoss
-9057000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
4928000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
4804000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
546000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
421000 usd
ANIX Common Stock Issued To Consultants
CommonStockIssuedToConsultants
72000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
5000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
31000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
44000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
400000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
119000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
91000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-25000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
103000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
89000 usd
ANIX Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-28000 usd
ANIX Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-45000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4899000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3893000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
11159000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
10399000 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
10348000 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
3640000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
35000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-811000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6724000 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
22500000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2208000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
11175000 usd
ANIX Payments Of Market Offering
PaymentsOfMarketOffering
341000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
6000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
3000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
830000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
293000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
836000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
31422000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4874000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
20805000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
29128000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6417000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
24254000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
27222000 usd
CY2021Q4 us-gaap Minority Interest
MinorityInterest
-671000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-123000 usd
CY2022Q3 us-gaap Minority Interest
MinorityInterest
-794000 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.58
CY2022Q3 ANIX Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding And Exercisable Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue
840000 usd
ANIX Revenue Percentage
RevenuePercentage
1 pure
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1642000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.58
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
956388 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.58
CY2022Q3 ANIX Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding And Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber
685612 shares
CY2022Q3 ANIX Money Market Funds Cash And Cash Equivalents
MoneyMarketFundsCashAndCashEquivalents
22254000 usd
CY2022Q3 ANIX Certificates Of Deposit Cash And Cash Equivalents
CertificatesOfDepositCashAndCashEquivalents
2000000 usd
CY2022Q3 ANIX Certificates Of Deposit Short Term Investments
CertificatesOfDepositShortTermInvestments
7410000 usd
CY2022Q3 ANIX Financial Assets
FinancialAssets
31664000 usd
CY2021Q4 ANIX Money Market Funds Cash And Cash Equivalents
MoneyMarketFundsCashAndCashEquivalents
28949000 usd
CY2021Q4 ANIX Certificates Of Deposit Short Term Investments
CertificatesOfDepositShortTermInvestments
2000000 usd
CY2021Q4 ANIX Treasury Bills And Bonds Short Term Investments
TreasuryBillsAndBondsShortTermInvestments
4599000 usd
CY2021Q4 ANIX Financial Assets
FinancialAssets
35548000 usd
CY2022Q3 us-gaap Accrued Payroll Taxes Current And Noncurrent
AccruedPayrollTaxesCurrentAndNoncurrent
621000 usd
CY2021Q4 us-gaap Accrued Payroll Taxes Current And Noncurrent
AccruedPayrollTaxesCurrentAndNoncurrent
492000 usd
CY2022Q3 us-gaap Accrued Royalties Current And Noncurrent
AccruedRoyaltiesCurrentAndNoncurrent
577000 usd
CY2021Q4 us-gaap Accrued Royalties Current And Noncurrent
AccruedRoyaltiesCurrentAndNoncurrent
577000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
26000 usd
CY2022Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
1198000 usd
CY2021Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
1095000 usd
CY2022Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
0 usd
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
0 usd
CY2022Q3 us-gaap Payments For Rent
PaymentsForRent
17000 usd
CY2021Q3 us-gaap Payments For Rent
PaymentsForRent
16000 usd
us-gaap Payments For Rent
PaymentsForRent
50000 usd
us-gaap Payments For Rent
PaymentsForRent
48000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
16000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
66000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
67000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
70000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
65000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
284000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
53000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
231000 usd
us-gaap Revenues
Revenues
513000 usd
ANIX Royalty Expense And Licensing Expense
RoyaltyExpenseAndLicensingExpense
385000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4 numbers
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-2775000 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-4388000 usd
us-gaap Profit Loss
ProfitLoss
-10242000 usd
us-gaap Profit Loss
ProfitLoss
-9057000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-2775000 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-4388000 usd
us-gaap Profit Loss
ProfitLoss
-10242000 usd
us-gaap Profit Loss
ProfitLoss
-9057000 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
2797000 usd
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
4388000 usd
us-gaap Costs And Expenses
CostsAndExpenses
10266000 usd
us-gaap Costs And Expenses
CostsAndExpenses
9572000 usd
CY2022Q3 ANIX Noncash Sharebased Compensation
NoncashSharebasedCompensation
-1438000 usd
CY2021Q3 ANIX Noncash Sharebased Compensation
NoncashSharebasedCompensation
-3187000 usd
ANIX Noncash Sharebased Compensation
NoncashSharebasedCompensation
-5474000 usd
ANIX Noncash Sharebased Compensation
NoncashSharebasedCompensation
-5225000 usd
CY2022Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1359000 usd
CY2021Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1201000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
4792000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
4347000 usd
CY2022Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1359000 usd
CY2021Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1201000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
4792000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
4347000 usd
CY2022Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1359000 usd
CY2021Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1201000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
4792000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
4347000 usd
CY2022Q3 us-gaap Assets
Assets
32563000 usd
CY2021Q4 us-gaap Assets
Assets
36257000 usd
CY2022Q3 us-gaap Assets
Assets
32563000 usd
CY2021Q4 us-gaap Assets
Assets
36257000 usd

Files In Submission

Name View Source Status
0001493152-22-025490-index-headers.html Edgar Link pending
0001493152-22-025490-index.html Edgar Link pending
0001493152-22-025490.txt Edgar Link pending
0001493152-22-025490-xbrl.zip Edgar Link pending
anix-20220731.xsd Edgar Link pending
ex10-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
anix-20220731_cal.xml Edgar Link unprocessable
anix-20220731_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
anix-20220731_lab.xml Edgar Link unprocessable
anix-20220731_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending